AVEO PHARMACEUTICALS INC (AVEO) is a publicly traded company in the Unknown sector. Across all available filings, 40 corporate insiders have executed 680 transactions totaling $237.2M, demonstrating a bullish sentiment with $198.5M in net insider flow. The most recent transaction on Jan 19, 2023 involved a transaction of 333,167 shares valued at $5.0M.
No significant insider buying has been recorded for AVEO in the recent period.
No significant insider selling has been recorded for AVEO in the recent period.
Based on recent SEC filings, insider sentiment for AVEO is bullish with an Insider Alignment Score of 92/100 and a net flow of $198.5M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at AVEO PHARMACEUTICALS INC (AVEO) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 40 insiders are actively trading AVEO stock, having executed 680 transactions in the past 90 days. The most active insider is Anthony A. Florence Jr (Executive), who has made 34 transactions totaling $24.6M.
Get notified when executives and directors at AVEO file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Jan 19, 2023 | P. Bailey Michael | Executive | Disposition | 333,167 | $15.00 | $5.0M | Large |
| Jan 19, 2023 | Ferraresso Michael | Executive | Disposition | 16,345 | $15.00 | $245.2K | |
| Jan 19, 2023 | B. Evnin Anthony | Executive | Disposition | 41,841 | $15.00 | $627.6K | Large |
| Jan 19, 2023 | Bate Kenneth | Executive | Disposition | 375 | $15.00 | $5.6K | |
| Dec 20, 2022 | P. Bailey Michael | Executive | Option Exercise | 164,525 | $3.67 | $603.8K | Large |
| Dec 20, 2022 | P. Bailey Michael | Executive | Option Exercise | 85,722 | $5.60 | $480.0K | |
| Dec 20, 2022 | P. Bailey Michael | Executive | Option Exercise | 26,499 | $6.20 | $164.3K | |
| Oct 19, 2022 | Opportunities Fund Iv, Llc Growth Equity | Executive | Other | 3,952,957 | $N/A | $0 | |
| Oct 19, 2022 | Associates 15, L.p. New Enterprise | Executive | Other | 3,952,957 | $N/A | $0 | |
| Oct 19, 2022 | Associates 15, L.p. New Enterprise | Executive | Other | 3,952,957 | $N/A | $0 | |
| Oct 19, 2022 | Associates 15, L.p. New Enterprise | Executive | Other | 3,952,957 | $N/A | $0 | |
| Oct 19, 2022 | 15, L.p. Nea Partners | Executive | Other | 3,952,957 | $N/A | $0 | |
| Oct 19, 2022 | 15, L.p. Nea Partners | Executive | Other | 3,952,957 | $N/A | $0 | |
| Oct 19, 2022 | 15, L.p. Nea Partners | Executive | Other | 59,294 | $N/A | $0 | |
| Oct 19, 2022 | 15, L.p. Nea Partners | Executive | Other | 3,952,957 | $N/A | $0 |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Purchase(P) | 289 | $217.8M | 88.6% |
Sale(S) | 165 | $19.4M | 7.9% |
Disposition(D) | 18 | $5.9M | 2.4% |
Exercise(M) | 65 | $2.5M | 1.0% |
Other(J) | 65 | $210.0K | 0.1% |
Award(A) | 48 | $173.6K | 0.1% |
Gift(G) | 4 | $0 | 0.0% |
Conversion(C) | 26 | $0 | 0.0% |
Insiders at AVEO PHARMACEUTICALS INC are accumulating shares at an accelerated pace. With 40 insiders making 680 transactions totaling $217.8M in purchases versus $19.4M in sales, the net buying activity of $198.5M signals strong executive confidence. Anthony A. Florence Jr (Executive) leads the buying activity with $24.6M in transactions across all time.